NCT07330414

Brief Summary

This is a long-term research registry for patients with Achilles tendon disorders (like tears, chronic pain, or ruptures) as well as healthy adults without tendon problems. The goal is to collect detailed information over time to understand which treatments work best for different people, identify risk factors for injury, and improve overall care. Adults over 18, both with and without Achilles tendon conditions, are eligible to join. Participants will attend several assessment visits at the Prince of Wales Hospital over the first year (at the start, 6 weeks, 3, 4, 6, and 12 months) for physical tests, ultrasounds, and questionnaires. After the first year, follow-up continues with annual online questionnaires for up to five years. The main measure is a standard questionnaire about tendon pain and function (VISA-A). The study aims to use this information to guide better, more personalized rehabilitation strategies, improve patient outcomes, and reduce long-term disability. All participation is voluntary and requires written consent.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
56mo left

Started Jan 2026

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Jan 2026Dec 2030

First Submitted

Initial submission to the registry

December 28, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 9, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

January 15, 2026

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2030

Expected
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2030

Last Updated

January 9, 2026

Status Verified

December 1, 2025

Enrollment Period

4.9 years

First QC Date

December 28, 2025

Last Update Submit

December 28, 2025

Conditions

Keywords

Achilles tendinopathyAchilles tendon ruptureAchilles tendinitis

Outcome Measures

Primary Outcomes (1)

  • Victorian Institute of Sports Assessment (VISA-A)

    The primary outcome measure will be the Victorian Institute of Sport Assessment (VISA-A) questionnaire, available in either the original English or validated Chinese version, depending on the participant's native language. This specific scoring system developed for the Achilles tendon is the most widely used score for clinical Achilles research. The VISA-A is scored on a scale of 0 to 100; lower scores indicate more severity of symptoms, while a score of 100 indicates a healthy and pain-free Achilles tendon.

    From enrollment to 5 years after baseline assessment

Secondary Outcomes (14)

  • Numeric Pain Rating Scale (NPRS)

    From enrollment to 5 years after baseline assessment

  • Foot and Ankle Outcome Scores (FAOS)

    From enrollment to 5 years after baseline assessment

  • Achilles tendon resting angle (ATRA)

    From enrollment to 1 year after baseline assessment

  • Royal London hospital test

    From enrollment to 1 year after baseline assessment

  • Calf Muscle Strength

    From enrollment to 1 year after baseline assessment

  • +9 more secondary outcomes

Study Arms (2)

Healthy group

Healthy individuals without any Achilles tendon injury

Achilles tendon disorder group

Individuals with any Achilles tendon disorder

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hong Kong Residents

You may qualify if:

  • Adults (\>18 years of age)

You may not qualify if:

  • Any physical or psychological comorbidity that would impair the ability to complete study assessments (e.g., significant neurological deficits) or preclude the provision of informed consent.
  • Concomitant diseases that severely affect lower limb function or assessment (e.g., severe osteoarthritis of the knee or hip, prior lower limb amputation, peripheral vascular disease, active rheumatoid arthritis, lower limb paralysis, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Ko VM, He X, Fu SC, Yung PS, Ling SK. Clinical effectiveness of pulsed electromagnetic field therapy as an adjunct treatment to eccentric exercise for Achilles tendinopathy: a randomised controlled trial. Trials. 2023 Jun 12;24(1):394. doi: 10.1186/s13063-023-07434-6.

    PMID: 37308969BACKGROUND
  • Ko VM, Chen SC, He X, Fu SC, Franco-Obregon A, Yung PS, Ling SK. Short-term Effects of Pulsed Electromagnetic Field Therapy for Achilles Tendinopathy: A Randomized Controlled Trial. Orthop J Sports Med. 2024 Nov 12;12(11):23259671241284772. doi: 10.1177/23259671241284772. eCollection 2024 Nov.

    PMID: 39534390BACKGROUND

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor of Orthopaedics and Traumatology, CUHK Head of the Foot and Ankle Team / Honorary Associate Consultant, Prince of Wales Hospital Specialist in Orthopaedics and Traumatology, CUHK Medical Centre

Study Record Dates

First Submitted

December 28, 2025

First Posted

January 9, 2026

Study Start

January 15, 2026

Primary Completion (Estimated)

December 15, 2030

Study Completion (Estimated)

December 30, 2030

Last Updated

January 9, 2026

Record last verified: 2025-12